Ποια είναι η τιμή για Akums Drugs & Pharmaceuticals Ltd. (AKUMS)

Η τιμή για Akums Drugs & Pharmaceuticals Ltd. (AKUMS) είναι $8.53

Ποια είναι η κεφαλαιοποίηση αγοράς για Akums Drugs & Pharmaceuticals Ltd. (AKUMS)

Η κεφαλαιοποίηση αγοράς για Akums Drugs & Pharmaceuticals Ltd. (AKUMS) είναι $1.31B

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) Τιμή και Κεφαλαιοποίηση Αγοράς

Akums Drugs & Pharmaceuticals Ltd. is an Indian-based company, established in 2004 and headquartered in Delhi, that operates globally as a manufacturer and supplier of both finished pharmaceutical products and active pharmaceutical ingredients (APIs). Its diverse product range encompasses conventional drugs, traditional Ayurvedic and herbal remedies, personal care items including toiletries, nutraceuticals, food and dietary supplements, dermatological and cosmetic products, and healthcare and hospital supplies, along with over-the-counter (OTC) solutions. The company also deals in excipients and various chemical compounds. Akums develops and markets its own branded formulations across a variety of dosage forms, such as tablets, capsules, injectables, ophthalmic preparations, and soft gelatin capsules. These products address a broad spectrum of therapeutic areas, including gynaecology, cardiology, orthopaedics, pediatrics, dermatology, anti-infectives, pain management, and gastroenterology. Furthermore, Akums Drugs & Pharmaceuticals provides services as a pharmaceutical contract development and manufacturing organization (CDMO).

Η τιμή για AKUMS	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$34,381.43 $1.31B	NVDA	$5.264T	+403,138.84%
$30,706.81 $1.31B	AAPL	$4.701T	+360,041.47%
$27,283.62 $1.31B	GOOG	$4.177T	+319,892.90%
$24,933.70 $1.31B	MSFT	$3.817T	+292,332.20%
$18,721.74 $1.31B	AMZN	$2.866T	+219,475.87%

Η τιμή για AKUMS

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$34,381.43 $1.31B